Growth and performance of Atlantic salmon, Salmo salar L., following administration of a rhabdovirus DNA vaccine alone or concurrently with an oil-adjuvanted, polyvalent vaccine

Journal of Fish Diseases

Volumn 31, Issue 9, 2008, Pages 687-697

  Skinner, L A ^a   Schulte, P M ^a   Lapatra, S E ^b   Balfry, S K ^a   McKinley, R S ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CLEAR SPRINGS FOODS INC   (United States)

Author keywords

DNA vaccine; Growth; Polyvalent vaccine; Salmon; Side effects; Vaccination

Indexed keywords

DNA VACCINE; IMMUNOLOGICAL ADJUVANT; OIL; VIRUS VACCINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; ATLANTIC SALMON; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FISH DISEASE; GROWTH; GROWTH, DEVELOPMENT AND AGING; MOTOR ACTIVITY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RHABDOVIRUS; SWIMMING; TIME; VIRUS INFECTION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BODY WEIGHT; FISH DISEASES; GROWTH; MOTOR ACTIVITY; OILS; RHABDOVIRIDAE; RHABDOVIRIDAE INFECTIONS; SALMO SALAR; SWIMMING; TIME FACTORS; VACCINES, DNA; VIRAL VACCINES;

RHABDOVIRIDAE; SALMO SALAR;

EID: 49349099477     PISSN: 01407775     EISSN: 13652761     Source Type: Journal    
DOI: 10.1111/j.1365-2761.2008.00945.x     Document Type: Article

References (32)

1. Ackerman P.A., Iwama G.K. Thornton J.C. (2000) Physiological and immunological effects of adjuvanted Aeromonas salmonicida vaccines on juvenile rainbow trout. Journal of Aquatic Animal Health 12, 157 164.
2. Anderson D.P. (1997) Adjuvants and immunostimulants for enhancing vaccine potency in fish. In : Fish Vaccinology (ed. by R. Gudding, A. Lillehaug, P.J. Midtlyng F. Brown). Developments in Biological Standardisation 90, 257 265. Karger, Basel.
3. Berg A., Rødseth O.M. Hansen T. (2007) Fish size at vaccination influences the development of side-effects in Atlantic salmon (Salmo salar L.). Aquaculture 265, 9 15.
4. Brett J.R. (1964) The respiratory metabolism and swimming performance of young sockeye salmon. Journal of the Fisheries Research Board of Canada 21, 1183 1226.
5. Buchmann K., Dalsgaard I., Nielsen M.E., Pedersen K., Uldal A., Garcia J.A. Larsen J.L. (1997) Vaccination improves survival of Baltic salmon (Salmo salar) smolts in delayed release sea ranching (net-pen period). Aquaculture 156, 335 348.
6. Busch R.A. (1997) Polyvalent vaccines in fish: the interactive effects of multiple antigens. In : Fish Vaccinology (ed. by R. Gudding, A. Lillehaug, P.J. Midtlyng F. Brown). Developments in Biological Standardisation 90, 245 256. Karger, Basel.
7. Corbeil S., LaPatra S.E., Anderson E.D. Kurath G. (2000) Nanogram quantities of a DNA vaccine protect rainbow trout fry against heterologous strains of infectious hematopoietic necrosis virus. Vaccine 18, 2817 2824.
8. Ellis A.E. (1999) Immunity to bacteria in fish. Fish and Shellfish Immunology 9, 291 308.
9. Evensen Ø., Brudeseth B. Mutoloki S. (2005) The vaccine formulation and its role in inflammatory processes in fish - effects and adverse effects. In : Progress in Fish Vaccinology (ed. by P.J. Midtlyng). Developments in Biological Standardisation 121, 117 125. Karger, Basel.
10. Gregory T.R. Wood C.M. (1998) The effects of chronic plasma cortisol elevation on the feeding behaviour, growth, competitive ability, and swimming performance of juvenile rainbow trout. Physiological and Biochemical Zoology 72, 286 295.
11. Heppell J. Davis H.L. (2000) Application of DNA vaccine technology to aquaculture. Advanced Drug Delivery Reviews 42, 29 43.
12. Jain K.E., Hamilton J.C. Farrell A.P. (1997) Use of a ramp velocity test to measure critical swimming speed in rainbow trout (Onchorhynchus mykiss). Comparative Biochemistry and Physiology 117A, 441 444.
13. Jain K.E., Birtwell I.K. Farrell A.P. (1998) Repeat swimming performance of mature sockeye salmon following a brief recovery period: a proposed measure of fish health and water quality. Canadian Journal of Zoology 76, 1488 1496.
14. Kurath G. (2005) Overview of recent DNA vaccine development for fish. In : Fish Vaccinology (ed. by P.J. Midtlyng). Developments in Biological Standardisation 121, 201 214. Karger, Basel.
15. LaPatra S.E., Corbeil S., Jones G.R., Shewmaker W.D., Lorenzen M., Anderson E.D. Kurath G. (2001) Protection of rainbow trout against infectious hematopoietic necrosis virus four days after specific or semi-specific DNA vaccination. Vaccine 19, 4011 4019.
16. Lorenzen N. LaPatra S.E. (1999) Immunity to rhabdoviruses in rainbow trout: the antibody response. Fish and Shellfish Immunology 9, 345 360.
17. Lorenzen N. LaPatra S.E. (2005) DNA vaccines for aquacultured fish. Revue Scientifique et Technique - Office International des Epizooties 24, 201 213.
18. Melingen G.O. Wergeland H.I. (2002) Physiological effects of an oil-adjuvanted vaccine on out-of-season Atlantic salmon (Salmo salar L.) smolt. Aquaculture 214, 397 409.
19. Melingen G.O., Pettersen E.F. Wergeland H.I. (2002) Leucocyte populations and responses to immunization and photoperiod manipulation in Atlantic salmon (Salmo salar L.) 0 + smolt. Aquaculture 214, 381 396.
20. Midtlyng P.J. (1996) A field study on intraperitoneal vaccination of Atlantic salmon (Salmo salar L.) against furunculosis. Fish and Shellfish Immunology 6, 553 565.
21. Midtlyng P.J. (1997) Vaccinated fish welfare: protection versus side-effects. In : Fish Vaccinology (ed. by R. Gudding, A. Lillehaug, P.J. Midtlyng F. Brown). Developments in Biological Standardisation 90, 371 379. Karger, Basel.
22. Midtlyng P.J., Reitan L.J. Speilberg L. (1996) Experimental studies on the efficacy and side-effects of intraperitoneal vaccination of Atlantic salmon (Salmo salar L.) against furunculosis. Fish and Shellfish Immunology 6, 335 350.
23. Plaut I. (2000) Critical swimming speed: its ecological relevance. Comparative Biochemistry and Physiology A 131, 41 50.
24. Poppe T.T. Breck O. (1997) Pathology of Atlantic salmon Salmo salar intraperitoneally immunized with oil-adjuvanted vaccine. A case report. Diseases of Aquatic Organisms 29, 219 226.
25. Pylkkö P., Lyytikäinen T., Ritola O. Sinikka Pelkonen S. (2000) Vaccination influences growth of Arctic charr. Diseases of Aquatic Organisms 43, 77 80.
26. Robinson H.L. (1997) Nucleic acid vaccines: an overview. Vaccine 15, 785 787.
27. Rønsholdt B. McLean E. (1999) The effect of vaccination and vaccine components upon short-term growth and feed conversion efficiency in rainbow trout. Aquaculture 174, 213 221.
28. Schijns V.E.J.C. Tangerås A. (2005) Vaccine adjuvant technology: from theoretical mechanisms to practical approaches. In : Progress in Fish Vaccinology (ed. by P.J. Midtlyng). Developments in Biological Standardisation 121, 127 134. Karger, Basel.
29. Soivio A., Nyholm K. Huhti M. (1977) Effects of anesthesia with MS 222, neutralized MS 222 and benzocaine on the blood constituents of rainbow trout, Salmo gairdneri. Journal of Fish Biology 10, 91 101.
30. Sørum U. Damsgård B. (2004) Effects of anaesthetisation and vaccination on feed intake and growth in Atlantic salmon (Salmo salar L.). Aquaculture 232, 333 341.
31. Tierney K.B. Farrell A.P. (2004) The relationships between fish health, metabolic rate, swimming performance, and recovery in return-run sockeye salmon, Oncorhynchus nerka (Walbaum). Journal of Fish Diseases 27, 663 671.
32. Tierney K.B., Balfry S.K. Farrell A.P. (2005) Subclinical Listonella anguillarum infection does not impair recovery of swimming performance in rainbow trout Oncorhynchus mykiss. Diseases of Aquatic Organisms 67, 81 86.